Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Neurobeachin regulates receptor downscaling at GABAergic inhibitory synapses in a protein kinase A-dependent manner.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE
    • Publication Information:
      Original Publication: London, United Kingdom : Nature Publishing Group UK, [2018]-
    • Subject Terms:
    • Abstract:
      GABAergic synapses critically modulate neuronal excitability, and plastic changes in inhibitory synaptic strength require reversible interactions between GABA A receptors (GABA A Rs) and their postsynaptic anchor gephyrin. Inhibitory long-term potentiation (LTP) depends on the postsynaptic recruitment of gephyrin and GABA A Rs, whereas the neurotransmitter GABA can induce synaptic removal of GABA A Rs. However, the mechanisms and players underlying plastic adaptation of synaptic strength are incompletely understood. Here we show that neurobeachin (Nbea), a receptor trafficking protein, is a component of inhibitory synapses, interacts with gephyrin and regulates the downscaling of inhibitory synaptic transmission. We found that the recruitment of Nbea to GABAergic synapses is activity-dependent and that Nbea regulates GABA A R internalization in a protein kinase A (PKA)-dependent manner. In heterozygous neurons lacking one Nbea allele, re-expression of Nbea but not expression of a PKA binding-deficient Nbea mutant rescued the internalization of GABA A Rs. Our data suggest a mechanism by which Nbea mediates PKA anchoring at inhibitory postsynaptic sites to downregulate GABAergic transmission. They emphasize the importance of kinase positioning in the regulation of synaptic strength.
      Competing Interests: Competing interests: The authors declare no competing interests.
      (© 2024. The Author(s).)
    • References:
      J Physiol. 2009 Nov 1;587(Pt 21):5095-106. (PMID: 19723784)
      Cell Rep. 2018 May 29;23(9):2705-2717. (PMID: 29847800)
      Curr Mol Med. 2011 Apr;11(3):204-17. (PMID: 21375492)
      Biochem Biophys Res Commun. 2011 Sep 2;412(3):435-40. (PMID: 21821005)
      EMBO J. 2014 Sep 17;33(18):2113-33. (PMID: 25082542)
      Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3616-21. (PMID: 18305175)
      J Biol Chem. 2013 Apr 5;288(14):9634-9647. (PMID: 23408424)
      Neurobiol Dis. 2006 Jan;21(1):217-27. (PMID: 16087343)
      Nat Commun. 2014 Jun 04;5:3921. (PMID: 24894704)
      Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20039-44. (PMID: 19903874)
      Front Cell Neurosci. 2014 Apr 09;8:103. (PMID: 24782709)
      iScience. 2019 Dec 20;22:453-465. (PMID: 31835170)
      Behav Brain Res. 2020 Apr 6;383:112509. (PMID: 31987933)
      J Med Genet. 2003 May;40(5):352-6. (PMID: 12746398)
      Nat Commun. 2011 Nov 22;2:557. (PMID: 22109531)
      Mol Cell Neurosci. 2003 Jan;22(1):87-97. (PMID: 12595241)
      Sci Signal. 2022 Jun 21;15(739):eabg2505. (PMID: 35727864)
      Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20795-800. (PMID: 24297911)
      EMBO J. 2007 Apr 4;26(7):1761-71. (PMID: 17347650)
      J Neurosci. 2000 Dec 1;20(23):8551-65. (PMID: 11102458)
      EMBO J. 2006 Mar 22;25(6):1385-95. (PMID: 16511563)
      eNeuro. 2023 Oct 6;10(10):. (PMID: 37734950)
      Nat Commun. 2014 Dec 22;5:5767. (PMID: 25531214)
      Mol Psychiatry. 2019 Sep;24(9):1248-1257. (PMID: 31089192)
      Curr Protoc Neurosci. 2020 Jun;92(1):e97. (PMID: 32364672)
      Histochem Cell Biol. 2018 Nov;150(5):489-508. (PMID: 30264265)
      J Biol Chem. 2001 Jul 6;276(27):25294-301. (PMID: 11325967)
      Neurobiol Dis. 2013 Mar;51:144-51. (PMID: 23153818)
      Neuron. 2009 Sep 10;63(5):628-42. (PMID: 19755106)
      Science. 1973 Sep 7;181(4103):952-4. (PMID: 4354229)
      Sci Signal. 2020 Dec 22;13(663):. (PMID: 33443230)
      J Neurochem. 1991 Oct;57(4):1307-12. (PMID: 1654391)
      J Neurosci. 2005 Nov 9;25(45):10469-78. (PMID: 16280585)
      Sci Rep. 2020 Sep 29;10(1):16058. (PMID: 32994505)
      Nat Commun. 2022 Jun 18;13(1):3507. (PMID: 35717442)
      Ann Neurol. 2018 Nov;84(5):788-795. (PMID: 30269351)
      J Cell Biol. 2013 Jan 7;200(1):61-80. (PMID: 23277425)
      J Neurosci. 2004 Apr 7;24(14):3627-36. (PMID: 15071111)
      Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14871-6. (PMID: 16192353)
      Brain Res. 1984 Jul 23;306(1-2):327-32. (PMID: 6087977)
      Mol Neurobiol. 2016 May;53(4):2112-23. (PMID: 25934101)
      Nat Commun. 2014 Oct 09;5:5066. (PMID: 25297980)
      Prog Neurobiol. 2003 Dec;71(6):401-37. (PMID: 15013227)
      J Neurosci. 1999 Nov 1;19(21):9289-97. (PMID: 10531433)
      Front Mol Neurosci. 2008 Mar 28;1:2. (PMID: 18946535)
      J Biol Chem. 2005 Apr 29;280(17):16962-16968. (PMID: 15718245)
      Commun Integr Biol. 2010 Mar;3(2):176-8. (PMID: 20585515)
      Nat Rev Neurosci. 2008 May;9(5):331-43. (PMID: 18382465)
      Psychopharmacology (Berl). 2014 Sep;231(17):3453-65. (PMID: 24847959)
      Brain Res Bull. 2021 Feb;167:11-21. (PMID: 33197534)
      Eur J Cell Biol. 2015 Mar-Apr;94(3-4):173-8. (PMID: 25701174)
      Nat Rev Neurosci. 2014 Mar;15(3):141-56. (PMID: 24552784)
      Nat Neurosci. 1998 Nov;1(7):563-71. (PMID: 10196563)
      Trends Neurosci. 2000 Sep;23(9):429-35. (PMID: 10941193)
      J Neurosci. 2012 Feb 15;32(7):2485-98. (PMID: 22396422)
      J Neurosci. 2014 Jan 15;34(3):804-16. (PMID: 24431439)
      J Biol Chem. 2020 Aug 28;295(35):12330-12342. (PMID: 32620552)
      J Neurosci. 2000 Nov 1;20(21):7972-7. (PMID: 11050117)
      Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):E65-72. (PMID: 25535349)
      Neuron. 2011 May 12;70(3):385-409. (PMID: 21555068)
      Science. 1968 Jul 4;165(3888):63-5. (PMID: 4306869)
    • Grant Information:
      KN556/16-1 Deutsche Forschungsgemeinschaft (German Research Foundation); KN556/17-1 Deutsche Forschungsgemeinschaft (German Research Foundation)
    • Accession Number:
      EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases)
      0 (gephyrin)
      0 (Receptors, GABA-A)
      0 (Membrane Proteins)
      0 (Carrier Proteins)
      0 (Nerve Tissue Proteins)
    • Publication Date:
      Date Created: 20241212 Date Completed: 20241212 Latest Revision: 20241215
    • Publication Date:
      20250114
    • Accession Number:
      PMC11638247
    • Accession Number:
      10.1038/s42003-024-07294-z
    • Accession Number:
      39668217